Intuitive Surgical, Inc. $ISRG Position Lifted by Krilogy Financial LLC

Krilogy Financial LLC boosted its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 79.9% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 12,467 shares of the medical equipment provider’s stock after purchasing an additional 5,538 shares during the period. Krilogy Financial LLC’s holdings in Intuitive Surgical were worth $5,331,000 as of its most recent SEC filing.

A number of other hedge funds have also recently modified their holdings of ISRG. Lineweaver Wealth Advisors LLC grew its position in shares of Intuitive Surgical by 15.4% in the 3rd quarter. Lineweaver Wealth Advisors LLC now owns 1,846 shares of the medical equipment provider’s stock worth $751,000 after buying an additional 246 shares during the last quarter. Davis Rea LTD. acquired a new stake in Intuitive Surgical in the 3rd quarter worth approximately $8,133,000. Seilern Investment Management Ltd lifted its stake in shares of Intuitive Surgical by 15.8% during the third quarter. Seilern Investment Management Ltd now owns 133,918 shares of the medical equipment provider’s stock worth $54,455,000 after buying an additional 18,223 shares during the period. Worthington Financial Partners LLC grew its stake in Intuitive Surgical by 1.3% during the 3rd quarter. Worthington Financial Partners LLC now owns 1,885 shares of the medical equipment provider’s stock valued at $767,000 after purchasing an additional 25 shares during the last quarter. Finally, Sax Wealth Advisors LLC boosted its position in Intuitive Surgical by 32.1% in the third quarter. Sax Wealth Advisors LLC now owns 4,381 shares of the medical equipment provider’s stock valued at $1,781,000 after buying an additional 1,065 shares during the last quarter. Institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Trading Down 1.3%

Shares of NASDAQ ISRG opened at $422.06 on Wednesday. The stock has a market cap of $149.11 billion, a P/E ratio of 48.35, a PEG ratio of 3.23 and a beta of 1.46. The business’s fifty day simple moving average is $388.49 and its 200-day simple moving average is $410.14. Intuitive Surgical, Inc. has a 12-month low of $328.57 and a 12-month high of $603.88.

Intuitive Surgical (NASDAQ:ISRG) last posted its earnings results on Thursday, July 16th. The medical equipment provider reported $2.80 EPS for the quarter, beating the consensus estimate of $2.48 by $0.32. The firm had revenue of $2.89 billion for the quarter, compared to analyst estimates of $2.83 billion. Intuitive Surgical had a return on equity of 16.91% and a net margin of 28.45%. Intuitive Surgical’s revenue for the quarter was up 18.4% compared to the same quarter last year. During the same quarter in the prior year, the company posted $1.81 earnings per share. On average, equities analysts forecast that Intuitive Surgical, Inc. will post 8.87 EPS for the current fiscal year.

Analysts Set New Price Targets

Several analysts recently commented on ISRG shares. HSBC lowered shares of Intuitive Surgical from a “buy” rating to a “hold” rating and set a $391.00 price target on the stock. in a research report on Thursday, July 30th. Evercore set a $430.00 price target on shares of Intuitive Surgical in a research note on Monday, July 6th. BTIG Research lowered their target price on Intuitive Surgical from $469.00 to $454.00 and set a “buy” rating on the stock in a report on Monday. BMO Capital Markets restated an “outperform” rating on shares of Intuitive Surgical in a research report on Monday, July 20th. Finally, UBS Group reiterated a “buy” rating on shares of Intuitive Surgical in a report on Tuesday. One investment analyst has rated the stock with a Strong Buy rating, twenty-two have issued a Buy rating, seven have issued a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, Intuitive Surgical presently has an average rating of “Moderate Buy” and a consensus target price of $498.83.

Intuitive Surgical News Roundup

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Intuitive Surgical is expanding beyond traditional surgery by submitting a next-generation robotic endoscope to the FDA for gastrointestinal procedures. Approval could open a significant new growth market and broaden the company’s recurring-procedure opportunity. ISRG Is Expanding Beyond Surgery: Here’s Why the GI Opportunity Matters
• Positive Sentiment: Zacks upgraded ISRG to Rank #2, or “Buy,” citing improving earnings prospects. The upgrade may support sentiment ahead of the company’s quarterly report. Intuitive Surgical Upgraded to Buy
• Positive Sentiment: UBS reiterated a Buy rating and maintained a $500 price target, pointing to Intuitive Surgical’s long-term robotic-surgery growth runway. Leerink Partners also maintained its Buy recommendation. Intuitive Surgical Buy Rating Reiterated
• Positive Sentiment: Erste Group raised its fiscal 2027 EPS estimate slightly to $10.09 from $10.06, above the current-year consensus estimate of $8.87, reinforcing expectations for continued earnings growth.
• Neutral Sentiment: Intuitive Surgical is being highlighted as a sales-growth stock ahead of third-quarter earnings. Its prior quarter included 18.4% year-over-year revenue growth and an earnings beat, but investors are likely waiting for updated results and guidance. 3 Sales Growth Stocks to Buy as Q3 Earnings Get Underway
• Negative Sentiment: BTIG lowered its price target to $454 from $469 while keeping a Buy rating. Although the revised target still implies upside, the cut may weigh on near-term sentiment and signals more cautious expectations.
• Negative Sentiment: Valuation remains a potential pressure point: Intuitive Surgical trades at a substantially higher forward earnings multiple than Abbott Laboratories, leaving the stock sensitive to any earnings miss, slower procedure growth, or conservative guidance. Abbott Laboratories vs. Intuitive Surgical

Insider Activity

In related news, EVP Gary Loeb sold 400 shares of the business’s stock in a transaction dated Monday, August 10th. The shares were sold at an average price of $379.00, for a total transaction of $151,600.00. Following the sale, the executive vice president owned 5,320 shares of the company’s stock, valued at approximately $2,016,280. The trade was a 6.99% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Gary S. Guthart sold 10,000 shares of the firm’s stock in a transaction on Tuesday, August 11th. The shares were sold at an average price of $400.00, for a total value of $4,000,000.00. Following the completion of the transaction, the director owned 1,245,679 shares of the company’s stock, valued at approximately $498,271,600. This represents a 0.80% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 12,370 shares of company stock worth $4,891,989 over the last 90 days. 0.60% of the stock is owned by corporate insiders.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops and commercializes robotic-assisted systems and related technologies designed to support minimally invasive medical procedures. The company’s products are intended to help surgeons perform operations through small incisions while providing enhanced visualization, precision, and control.

Its principal product is the da Vinci Surgical System, a platform used across a range of specialties, including general surgery, urology, gynecology, thoracic surgery, and cardiac procedures.